FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2020000623> ?p ?o ?g. }

• W2020000623 endingPage "533" @default.
• W2020000623 startingPage "517" @default.
• W2020000623 abstract "The antioxidant activity of L-carnosine (beta-alanyl-L-histidine, bioactivated in ocular tissues) versus N-acetylcarnosine (N-acetyl-beta-alanyl-L-histidine, ocular-targeted small dipeptide molecules) was studied in aqueous solution and in a lipid environment, employing liposomes as a model of lipid membranes. Reactive oxygen species (ROS) were generated by an iron/ascorbate promoter system for induction of lipid peroxidation (LPO). L-carnosine, which is stabilized from enzymatic hydrolysis, operates as a universal aldehyde and ROS scavenger in both aqueous and lipid environments and is effective at preventing ROS-induced damage to biomolecules. Second-generation carnosine analogs bearing the histidyl-hydrazide moiety were synthesized and tested versus L-carnosine for their ability to reverse the glycation process, also known as the Maillard reaction, and reverse the stable intermolecular cross-links, monitored in the glucose-ethylamine Schiff base model, ultimately resulting in the formation of the advanced glycation end products (AGEs) from nonenzymatic glycation, accumulating in numerous body tissues and fluids. The obtained data demonstrate the transglycation properties of the ophthalmically stabilized L-carnosine and L-carnosine histidyl-hydrazide derivatives tested and can be used to decrease or predict the occurrence of long-term complications of AGE formation and improve therapeutically the quality of vision and length of life for diabetes mellitus patients and survivors with early aging. Scientists at Innovative Vision Products, Inc. (IVP), developed lubricant eyedrops designed as a sustained-release 1% N-acetylcarnosine prodrug of L-carnosine. The eyedrops contain a mucoadhesive cellulose-based compound combined with corneal absorption promoters and glycerine in a drug-delivery system. Anti-aging therapeutics with the ophthalmic drug eyedrop formula including N-acetylcarnosine showed efficacy in the nonsurgical treatment of age-related cataracts for enrolled participants in the prospective, randomized, double-masked, placebo-controlled crossover clinical trial after controlling for age, gender, and daily activities. In a cohort in excess of 50,500 various patients seeking cutting-edge medical care, the N-acetylcarnosine topical eyedrops target therapy was demonstrated to have significant efficacy, safety, and good tolerability for the prevention and treatment of visual impairment in this older population with relatively stable patterns of causes for blindness and visual impairment. Overall, accumulated study data demonstrate that the IVP-designed new vision-saving drugs, including N-acetylcarnosine eyedrops, promote health vision and prevent vision disability from senile cataracts, primary open-angle glaucoma, age-related macular degeneration, diabetic retinopathy, and aging. N-acetylcarnosine eyedrop therapy is the crown jewel of the anti-aging medical movement and revolutionizes early detection, treatment, and rejuvenation of aging-related eye-disabling disorders. N-acetylcarnosine, as an innovative medical science tool and component of the home medicine and alternative medicine approaches, has the potential to alleviate visual impairment and its associated social, economic, and political woes for an aging population." @default.
• W2020000623 created "2016-06-24" @default.
• W2020000623 creator A5027453092 @default.
• W2020000623 creator A5032632823 @default.
• W2020000623 creator A5057671024 @default.
• W2020000623 creator A5085292075 @default.
• W2020000623 date "2009-11-01" @default.
• W2020000623 modified "2023-10-16" @default.
• W2020000623 title "N-Acetylcarnosine Lubricant Eyedrops Possess All-In-One Universal Antioxidant Protective Effects of L-Carnosine in Aqueous and Lipid Membrane Environments, Aldehyde Scavenging, and Transglycation Activities Inherent to Cataracts: A Clinical Study of the New Vision-Saving Drug N-Acetylcarnosine Eyedrop Therapy in a Database Population of Over 50,500 Patients" @default.
• W2020000623 cites W1508726918 @default.
• W2020000623 cites W1538991079 @default.
• W2020000623 cites W1971443720 @default.
• W2020000623 cites W1971920601 @default.
• W2020000623 cites W1976820709 @default.
• W2020000623 cites W1977895778 @default.
• W2020000623 cites W1982350953 @default.
• W2020000623 cites W1983707612 @default.
• W2020000623 cites W1994998336 @default.
• W2020000623 cites W1995086395 @default.
• W2020000623 cites W2002019037 @default.
• W2020000623 cites W2005546891 @default.
• W2020000623 cites W2018805264 @default.
• W2020000623 cites W2033420858 @default.
• W2020000623 cites W2040478432 @default.
• W2020000623 cites W2044289098 @default.
• W2020000623 cites W2048321718 @default.
• W2020000623 cites W2052184783 @default.
• W2020000623 cites W2064925671 @default.
• W2020000623 cites W2066019537 @default.
• W2020000623 cites W2070009772 @default.
• W2020000623 cites W2082865005 @default.
• W2020000623 cites W2122643622 @default.
• W2020000623 cites W2128783891 @default.
• W2020000623 cites W2130439126 @default.
• W2020000623 cites W2136565033 @default.
• W2020000623 cites W2148946761 @default.
• W2020000623 cites W2154647474 @default.
• W2020000623 doi "https://doi.org/10.1097/mjt.0b013e318195e327" @default.
• W2020000623 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19487926" @default.
• W2020000623 hasPublicationYear "2009" @default.
• W2020000623 type Work @default.
• W2020000623 sameAs 2020000623 @default.
• W2020000623 citedByCount "32" @default.
• W2020000623 countsByYear W20200006232012 @default.
• W2020000623 countsByYear W20200006232013 @default.
• W2020000623 countsByYear W20200006232014 @default.
• W2020000623 countsByYear W20200006232015 @default.
• W2020000623 countsByYear W20200006232016 @default.
• W2020000623 countsByYear W20200006232017 @default.
• W2020000623 countsByYear W20200006232018 @default.
• W2020000623 countsByYear W20200006232019 @default.
• W2020000623 countsByYear W20200006232020 @default.
• W2020000623 crossrefType "journal-article" @default.
• W2020000623 hasAuthorship W2020000623A5027453092 @default.
• W2020000623 hasAuthorship W2020000623A5032632823 @default.
• W2020000623 hasAuthorship W2020000623A5057671024 @default.
• W2020000623 hasAuthorship W2020000623A5085292075 @default.
• W2020000623 hasConcept C147990577 @default.
• W2020000623 hasConcept C170493617 @default.
• W2020000623 hasConcept C178790620 @default.
• W2020000623 hasConcept C185592680 @default.
• W2020000623 hasConcept C2778004101 @default.
• W2020000623 hasConcept C2780687331 @default.
• W2020000623 hasConcept C2780829032 @default.
• W2020000623 hasConcept C2994476132 @default.
• W2020000623 hasConcept C35378473 @default.
• W2020000623 hasConcept C55493867 @default.
• W2020000623 hasConceptScore W2020000623C147990577 @default.
• W2020000623 hasConceptScore W2020000623C170493617 @default.
• W2020000623 hasConceptScore W2020000623C178790620 @default.
• W2020000623 hasConceptScore W2020000623C185592680 @default.
• W2020000623 hasConceptScore W2020000623C2778004101 @default.
• W2020000623 hasConceptScore W2020000623C2780687331 @default.
• W2020000623 hasConceptScore W2020000623C2780829032 @default.
• W2020000623 hasConceptScore W2020000623C2994476132 @default.
• W2020000623 hasConceptScore W2020000623C35378473 @default.
• W2020000623 hasConceptScore W2020000623C55493867 @default.
• W2020000623 hasIssue "6" @default.
• W2020000623 hasLocation W20200006231 @default.
• W2020000623 hasLocation W20200006232 @default.
• W2020000623 hasOpenAccess W2020000623 @default.
• W2020000623 hasPrimaryLocation W20200006231 @default.
• W2020000623 hasRelatedWork W1925630024 @default.
• W2020000623 hasRelatedWork W2020000623 @default.
• W2020000623 hasRelatedWork W2026730612 @default.
• W2020000623 hasRelatedWork W2061894332 @default.
• W2020000623 hasRelatedWork W2070286101 @default.
• W2020000623 hasRelatedWork W2090764754 @default.
• W2020000623 hasRelatedWork W2099427598 @default.
• W2020000623 hasRelatedWork W2109140484 @default.
• W2020000623 hasRelatedWork W2156485820 @default.
• W2020000623 hasRelatedWork W2393658344 @default.
• W2020000623 hasVolume "16" @default.
• W2020000623 isParatext "false" @default.
• W2020000623 isRetracted "false" @default.
• W2020000623 magId "2020000623" @default.
• W2020000623 workType "article" @default.